Strongbridge is a Pennsylvania-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of rare diseases... Read more
Strongbridge is a Pennsylvania-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of rare diseases... Read more
News
Oct 06, 2021
The Business Journals: Philadelphia
Strongbridge Biopharma: Xeris Pharmaceuticals completes $267M acquisition of Strongbridge Biopharma
Sep 10, 2021
The Business Journals: Philadelphia
Strongbridge Biopharma: Strongbridge Biopharma shareholders overwhelmingly approve $267M merger deal
Aug 31, 2021
BioSpace
Strongbridge Biopharma: Second Leading Independent Proxy Advisory Firm Glass Lewis Recommends Strongbridge Biopharma plc Shareholders Vote "FOR" the Transaction With Xeris
Aug 31, 2021
StreetInsider
Press Release: Strongbridge Biopharma : Man Group PLC : Form 8.3 - Stonebridge Biopharma plc
Aug 31, 2021
MarketScreener
Strongbridge Biopharma: Strongbridge Biopharma : Certain Litigation Relating to the Transaction (Form 8-K)
Aug 30, 2021
BioSpace
Strongbridge Biopharma: Xeris Pharmaceuticals Announces Leading Independent Proxy Advisory Firm, ISS, Recommends Xeris Stockholders Vote "FOR" the Transaction With Strongbridge Biopharma
Aug 24, 2021
FE Investegate
Strongbridge Biopharma: Morgan Stanley Smith : Form 8.3 -STRONGBRIDGE BIOPHARMA PLC
Aug 16, 2021
MarketScreener
Strongbridge Biopharma: INVESTIGATION: Halper Sadeh LLP Investigates SBBP, QTS, GRA, SWN, ONEM, IKNX; Shareholders are Encouraged to Contact the Firm
Aug 05, 2021
Citybizlist
Strongbridge Biopharma: Strongbridge Biopharma plc Reports Second Quarter 2021 Financial Results and Provides Corporate Update
Aug 04, 2021
News Break
Strongbridge Biopharma: After Courting Many, Strongbridge Biopharma of Trevose Chose to Dance with a Chicago Pharmaceutical Firm - News Break
